With a dynamic blend of experiences from Pfizer to McKinsey, and a strong background in healthcare, Dr. Bains is looking forward to working closely with the team and stakeholders to accelerate ImpediMed’s growth. Her journey spans from the US to Asia, the Middle East, and Australia, focusing on delivering healthcare breakthroughs to all patients and healthcare professionals, including in breast cancer care.
Parmjot Bains Appointed as M.D and C.E.O of ImpediMed
